Extramedullary relapse and discordant CD19 expression between bone marrow and extramedullary sites in relapsed acute lymphoblastic leukemia after blinatumomab treatment
-
Published:2019-06
Issue:3
Volume:43
Page:222-227
-
ISSN:0147-0272
-
Container-title:Current Problems in Cancer
-
language:en
-
Short-container-title:Current Problems in Cancer
Author:
Demosthenous Christos,
Lalayanni Chrysavgi,
Iskas Michalis,
Douka Vassiliki,
Pastelli Nikoleta,
Anagnostopoulos AchillesORCID
Subject
Cancer Research,Oncology
Reference16 articles.
1. Intensified and shortened cyclical chemotherapy for adult acute lymphoblastic leukemia;Linker;J Clin Oncol,2002
2. Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation;Gokbuget;Blood,2012
3. Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study;Fielding;Blood,2007
4. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues;Swerdlow,2008
5. Flow cytometric study of potential target antigens (CD19, CD20, CD22, CD33) for antibody-based immunotherapy in acute lymphoblastic leukemia: analysis of 552 cases;Raponi;Leuk Lymphoma,2011
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献